Medical Science Liaison, France

About BridgeBio Pharma, Inc. 

BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide. 

Who We Are 

BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fuelling the company’s international growth. 

At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world. 

To learn more about our story and company culture, visit us at https://bridgebio.com

What You'll Do

You will report to the Senior Medical Director, WEU Region and work closely with other MSLs, local Market Access, Commercial team, and regional and global Medical Affairs to execute our Medical Affairs brand plan and related strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients with genetic diseases and genetically driven cancers. 

Your primary purpose will be to build our KOL and HCP base in the pre-launch and launch phase, as BridgeBio engages with most customers in France for the first time. You will work on our initiatives during early pre-launch through post-launch, ensure medical and scientific education of HCPs as part of our launch efforts, engage with HCPs to increase diagnosis rates and support market access related work as a key stakeholder. 

This role requires effective collaboration with cross-functional colleagues and external stakeholders to ensure high-quality execution and impact. The ideal candidate combines deep expertise in medical and scientific engagement in the context of introducing a biotech company for the first time to KOLs, medical and scientific engagement and making a remarkable contribution to a disease space in pre-launch and launch phase in a rare disease and orphan condition. We look for strong scientific acumen, communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment.

Responsibilities

• Identify relevant HCPs and map the treatment landscape in scope, including patient journey with diagnosis, treatment, referral and centres of excellence
• Deliver pre-launch activities to ensure medical readiness, including disease state education, unmet need articulation, initiatives to significantly improve diagnosis rates, and structured scientific exchange planning and KOL engagement
• Support identification, prioritization, and delivery of high-impact medical research initiatives aligned with business objectives, including BridgeBio-sponsored and investigator-initiated studies, for generation of locally relevant data
• Co-design and deliver insight-generation and medical education activities, including advisory boards, congress symposia, standalone meetings, hospital-based education, and speaker development programs
• Leverage AI and digital technologies to enhance medical insights generation, stakeholder engagement, knowledge management, and operational efficiency, ensuring compliant, ethical, and value-driven use of emerging digital solutions
• Regular review of relevant literature, participation in scientific congresses and conferences, including BridgeBio therapeutic area training sessions to maintain current knowledge and to develop competitive intelligence on other treatments in the therapeutic area
• Design and deliver internal training materials and sessions for onboarding of new colleagues as well as continuous education, and support review of materials

The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow. 

Where You'll Work

This is a France field-based role with a strong customer facing component. In addition to the travel across the whole of France, we anticipate European travel for conference attendance, KOL meetings and speaker program attendance. Local team meetings and designated office location in France is Paris. Preferred personal location is Paris or Ile-de-France region.

Who You Are

• Master of Science degree required. PhD, PharmD, or MD preferred
• Minimum 5-7 years of field-based Medical Affairs experience in rare diseases and orphan conditions
• Experience in endocrinology and achondroplasia or bone growth disorders with a genetic cause is a plus
• Excellent interpersonal communication and presentation skills, including the ability to network. Able to participate in a scientific dialogue with KOLs and researchers
• Proven ability to create and sustain relationships with key scientific experts, and to handle objections and manage issues presented by HCPs
• Experience in initiating diagnostics initiative is a plus
• Self-starter, entrepreneurial, with can-do mindset and ability and willingness to organize, prioritize, and work effectively with minimal supervision in a biotech build-out environment

Rewarding Those Who Make the Mission Possible

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.  

• Market leading compensation 
• Hybrid work model - we value your flexibility in how you work, but encourage time in the office to strengthen our culture, collaboration, and sense of community
• We provide career development through regular feedback, continuous education and professional development programs
• We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities